PTGS2 and hepatocellular carcinoma: SSd also controls HCC cell proliferation by suppressing the phosphorylated signal transducer and activator of transcription 3 CCAAT/enhancer binding protein beta (p-STAT3/C/EBPβ) signaling pathway and inhibits cyclooxygenase-2 (COX-2) expression [29].